Vioxx Missouri Consumer Fraud Settlement
Merck settled a class-action lawsuit filed on behalf of Missouri consumers of Merck’s Vioxx pain medication. The lawsuit alleged that Merck violated the Missouri Merchandising Practices Act by concealing and/or downplaying the cardiovascular risks of Vioxx. Pursuant to the settlement agreement, Merck made an initial payment of $39 million. It was reported that the settlement could ultimately cost Merck up to $220 million.
- Misconduct Type
- Enforcement Agency
- Contracting Party
- Court Type
- Date of Settlement Announcement
|Merck & Co., Inc.||$39,000,000|